Lighthouse Investment Partners, LLC
Position in LLY — ELI LILLY & Co
CIK 1600344
Palm Beach Gardens, FL
Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,426,771
-$3,075,043 QoQ
Shares Held
2,857
-52.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#2,006
of 4,601 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lighthouse Investment Partners, LLC holds $17,722,466 across 7 Drug Manufacturers - General names. LLY ranks #2 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,975 | $4,057,170 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
2,857 | $3,426,771 | |
| 3 | NVO |
Novo Nordisk A S
|
67,554 | $3,238,538 | |
| 4 | ABBV |
AbbVie Inc.
|
10,270 | $2,584,342 | |
| 5 | BIIB |
Biogen Inc.
|
7,500 | $1,620,450 | |
| 6 | AZN |
Astrazeneca PLC
|
7,381 | $1,399,585 | |
| 7 | AMGN |
Amgen Inc
|
3,854 | $1,395,610 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,426,771 | 2,857 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $6,501,814 | 6,050 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,196,500 | 5,500 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,053,556 | 5,200 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,651,820 | 2,000 | Shares | Defined | 2025-05-15 | |
| 2024-06-30 | $23,121,594 | 25,538 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,460,822 | 5,734 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,168,459 | 10,582 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,602,129 | 8,568 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||